Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Cloutier

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|September 25, 2009
Recurrent sternal infection following treatment with negative pressure wound therapy and titanium transverse plate fixationGeneviève Gaudreau, Victor Costache, Chanel Houde, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|November 3, 2009
Impact of deep sternal wound infection management with vacuum-assisted closure therapy followed by sternal osteosynthesis: a 15-year review of 23,499 sternotomiesRichard Baillot, Daniel Cloutier, Livia Montalin, et al.
Journal of Cardiothoracic Surgery|November 15, 2012
Surgical site infections following transcatheter apical aortic valve implantation: incidence and managementRichard Baillot, Éric Fréchette, Daniel Cloutier, et al.
Journal of Experimental Botany|August 15, 2002
Decoupling of light intensity effects on the growth and development of C3 and C4 weed species through sucrose supplementationSultan H Begna, Lianne M Dwyer, Daniel Cloutier, et al.
Drugs in R&D|November 6, 2021
Clinical and Preclinical Single-Dose Pharmacokinetics of VIR-2218, an RNAi Therapeutic Targeting HBV InfectionSneha V Gupta, Marie C Fanget, Christopher MacLauchlin, et al.
Viruses|June 26, 2026
An Update on HIV Pre-Exposure Prophylaxis (PrEP) Among WomenTamara Barnett, Daniel Cloutier, Rafique Van Uum, et al.
The Journal of Antimicrobial Chemotherapy|October 7, 2016
Efficacy of ceftolozane/tazobactam against urinary tract and intra-abdominal infections caused by ESBL-producing Escherichia coli and Klebsiella pneumoniae: a pooled analysis of Phase 3 clinical trialsMyra W Popejoy, David L Paterson, Daniel Cloutier, et al.
The Lancet. Gastroenterology & Hepatology|October 10, 2024
VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 studyMan-Fung Yuen, Young-Suk Lim, Ki Tae Yoon, et al.
Journal of Hepatology|August 29, 2025
Engineered monoclonal antibody tobevibart enhances HBsAg capture by Fc receptor-positive cells and activates HBV-specific T cellsLucia Vincenzetti, Rachel Wong, Roberta Marzi, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|September 25, 2009
Recurrent sternal infection following treatment with negative pressure wound therapy and titanium transverse plate fixationGeneviève Gaudreau, Victor Costache, Chanel Houde, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|November 3, 2009
Impact of deep sternal wound infection management with vacuum-assisted closure therapy followed by sternal osteosynthesis: a 15-year review of 23,499 sternotomiesRichard Baillot, Daniel Cloutier, Livia Montalin, et al.
Journal of Cardiothoracic Surgery|November 15, 2012
Surgical site infections following transcatheter apical aortic valve implantation: incidence and managementRichard Baillot, Éric Fréchette, Daniel Cloutier, et al.
Journal of Experimental Botany|August 15, 2002
Decoupling of light intensity effects on the growth and development of C3 and C4 weed species through sucrose supplementationSultan H Begna, Lianne M Dwyer, Daniel Cloutier, et al.
Drugs in R&D|November 6, 2021
Clinical and Preclinical Single-Dose Pharmacokinetics of VIR-2218, an RNAi Therapeutic Targeting HBV InfectionSneha V Gupta, Marie C Fanget, Christopher MacLauchlin, et al.
Viruses|June 26, 2026
An Update on HIV Pre-Exposure Prophylaxis (PrEP) Among WomenTamara Barnett, Daniel Cloutier, Rafique Van Uum, et al.
The Journal of Antimicrobial Chemotherapy|October 7, 2016
Efficacy of ceftolozane/tazobactam against urinary tract and intra-abdominal infections caused by ESBL-producing Escherichia coli and Klebsiella pneumoniae: a pooled analysis of Phase 3 clinical trialsMyra W Popejoy, David L Paterson, Daniel Cloutier, et al.
The Lancet. Gastroenterology & Hepatology|October 10, 2024
VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 studyMan-Fung Yuen, Young-Suk Lim, Ki Tae Yoon, et al.
Journal of Hepatology|August 29, 2025
Engineered monoclonal antibody tobevibart enhances HBsAg capture by Fc receptor-positive cells and activates HBV-specific T cellsLucia Vincenzetti, Rachel Wong, Roberta Marzi, et al.
Pageof 1